Q1 Fiscal 2024 Capital Structure Review
CAUTIONARY
STATEMENT
This document is current as of December 31, 2023, except where otherwise
stated. The information contained in this presentation is provided by Organigram
Holdings Inc. ("Organigram" or the "Company") for informational purposes only
and does not constitute an offer to issue or arrange to issue, or the solicitation of
an offer to issue, securities of Organigram or other financial products. No part of
this presentation shall form the basis or be relied upon in connection with any
contract, commitment or investment decisions in relation thereto. The information
contained herein is not investment or financial product advice and is not intended
to be used as the basis for making an investment decision. No securities
commission or similar regulatory authority in Canada or the United States has
reviewed this presentation.
No representation or warranty, express or implied, is made as to the fairness,
accuracy, completeness or correctness of the information, opinions and
condusions contained in this presentation. This presentation is not meant to
provide a complete or comprehensive analysis of Organigram's financial or
business prospects. To the maximum extent permitted by law, none of
Organigram nor its directors, officers, employees or agents, nor any other person
accepts any liability, induding, without limitation, any liability arising out of fault or
negligence, for any loss arising from the use of the information contained in this
presentation.
This presentation contains forward-looking information. Often, but not always,
forward-looking information can be identified by the use of words such as "plans",
"expects", "estimates", "intends", "anticipates", "believes" or variations of such
words and phrases or state that certain actions, events, or results "may", "could",
"would", "might" or "will" be taken, occur or be achieved. Forward-looking
information involves known and unknown risks, uncertainties and other factors
that may cause actual results, events, performance or achievements of
Organigram to differ materially from current expectations or future results,
perfomance or achievements expressed or implied by the forward-looking
information contained in this presentation. Risks, uncertainties and other factors
involved with forward-looking information could cause actual events, results,
performance, prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information indude factors and risks
as disclosed in the Company's most recent annual information form,
management's discussion and analysis and other Company documents filed from
time to time on SEDAR+ (see www.sedarplus.com) and filed or fumished to the
Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers
are cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date of this presentation.
Although the Company believes that the assumptions and factors used in
preparing the forward-looking information in this presentation are reasonable,
undue reliance should not be placed on such information and no assurance can
be given that such events will occur in the disclosed time frames or at all. The
forward-looking information induded in this presentation is made as of the date of
this presentation and the Company disclaims any intention or obligation, except to
the extent required by law, to update or revise any forward-looking information,
whether as a result of new information, future events or otherwise. The
descriptions of the terms of the agreements referenced in this release are
qualified by the terms of the agreements themselves, copies of which shall be
filed under Organigram's profile on SEDAR+ (see www.sedarplus.com) and filed
or fumished to the Securities and Exchange Commission on EDGAR
(see www.sec.gov).
The financial information in this document contains certain financial performance
measures that are not defined by and do not have any standardized meaning
under IFRS and are used by management to assess the financial and operational
perfomance of the Company. These indude adjusted EBITDA and adjusted
gross margin (adjusted gross margin %). The Company believes that these non-
IFRS financial measures, in addition to conventional measures prepared in
accordance with IFRS, enable investors to evaluate the Company's operating
results, underlying performance and prospects in a similar manner to the
Company's management. As there are no standardized methods of calculating
these non-IFRS measures, the Company's approach may differ from those used
by other issuers, and accordingly, the use of these measures may not be directly
comparable. Accordingly, these non-IFRS measures are intended to provide
additional information and should not be considered in isolation or as a substitute
for measures of performance prepared in accordance with IFRS. For further
information regarding these non-IFRS measures, induding definitions, and a
quantitative reconciliation to the most directly comparable IFRS measure, see the
information under the heading "Cautionary Statement Regarding Certain Non-
IFRS Measures" and the reconciliation to IFRS measures under the heading
"Financial Results and Review of Operations" in the Company's management
discussion and analysis of financial conditions and results of operations for the
three months ended December 31, 2023 and November 30, 2022 (the "Q1 Fiscal
2024 MD&A") incorporated by reference in this presentation and filed under
Organigram's profile of SEDAR+ (see www.sedarplus.com) and filed or fumished
to the Securities and Exchange Commission on EDGAR (see www.sec.gov).
This presentation does not constitute an offer of shares for sale in the United
States or to any person that is, or is acting for the account or benefit of, any U.S.
person as defined in Regulation S under the United States Securities Act of 1933,
as amended (the "Securities Act") ("U.S. Person"), or in any other jurisdiction in
which such an offer would be illegal. Organigram's shares have not been and will
not be registered under the Securities Act. We seek safe harbour. This document
may not be reproduced, further distributed or published in whole or in part by any
other person. This document may only be disseminated or transmitted into any
jurisdiction in compliance with, and subject to, applicable securities laws. Readers
are required to ensure their compliance with applicable securities laws.
This investor presentation contains information concerning our industry and the
markets in which we operate, induding our market position and market share,
which is based on information from independent third-party sources. Although we
believe these sources to be generally reliable, market and industry data is
inherently imprecise, subject to interpretation and cannot be verified with complete
certainty due to limits on the availability and reliability of raw data, the voluntary
nature of the data gathering process, and other limitations and uncertainties
inherent in any statistical survey or data collection process. We have not
independently verified any third-party information contained herein.
ORGANIGRAM
2View entire presentation